Primary Care News

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Researchers developed a wearable jumpsuit with sensors that can objectively measure an infant’s gross motor development and, with the help of AI, identify milestones with more than 90% accuracy, according to findings reported in Pediatrics.

One question that freshly matriculated medical students become well-versed in answering is “what specialty are you interested in?”

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous induction options for the treatment of moderately to severely active Crohn’s disease, Johnson & Johnson reported.

The contraction inhibitor atosiban prolonged labor in cases of threatened preterm birth beyond 30 weeks’ gestation but did not improve neonatal outcomes compared with placebo, researchers reported in The Lancet.

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c at 30 weeks for adults with type 1 diabetes, according to findings from the INHALE-3 extension trial.

The American Academy of Dermatology has created a measles resource center for dermatologists to stay prepared during the current U.S. measles outbreak.

March is Traumatic Brain Injury Awareness Month, a condition that has led to permanent disability in more than 5 million individuals in the United States.

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of Belgium, Italy, Spain, the Netherlands and the U.K., according to results published in The Lancet Respiratory Medicine.